PTGS2 and Familial adenomatous polyposis: In FAP, we have previously shown that enhanced urinary PGEM is reduced by celecoxib (a selective COX-2 inhibitor), suggesting that it reflects the biosynthesis of PGE2 in vivo, mainly from COX-2 [35].